1 Our aim was to determine whether lipoamino acid conjugation of peptides that are high-affinity activators of ryanodine receptor (RyR) channels would (a) render the peptides membrane permeable, (b) alter their structure or (a) reduce their activity. The peptides correspond to the A region of the II-III loop of the skeletal dihydropyridine receptor. 2 The lipoamino acid conjugation increased the apparent permeability of the peptide across the Caco-2 cell monolayer by up to B20-fold. 3 Nuclear magnetic resonance showed that the a-helical structure of critical basic residues, required for optimal activation of RyRs, was retained after conjugation. 4 The conjugated peptides were more effective in enhancing resting Ca 2 þ release, Ca 2 þ -induced Ca 2 þ release and caffeine-induced Ca 2 þ release from isolated sarcoplasmic reticulum (SR) than their unconjugated counterparts, and significantly enhanced caffeine-induced Ca 2 þ release from mechanically skinned extensor digitorum longus (EDL) fibres. 5 The effect of both conjugated and unconjugated peptides on Ca 2 þ release from skeletal SR was 30-fold greater than their effect on either cardiac Ca 2 þ release or on the Ca 2 þ Mg 2 þ ATPase. 6 A small and very low affinity effect of the peptide in slowing Ca 2 þ uptake by the Ca 2 þ , Mg
Introduction
The ryanodine receptor (RyR) Ca 2 þ release channel is the sole conduit for Ca 2 þ release from internal stores in the sarcoplasmic reticulum (SR) to activate contraction in skeletal muscle and the heart. The RyR, either alone or in combination with the inositol 1,4,5-trisphosphate receptor (IP 3 R), is also found in the endoplasmic reticulum, mitochondria, nuclear envelope and secretory vesicles of many cell types, including smooth muscle, neurones and lymphocytes. Despite the importance of this ion channel, there are few drugs available that can be used either as experimental probes for RyR activity or for therapeutic purposes.
A 20 amino-acid peptide (peptide A), corresponding to a part of the loop between the second and third membrane-spanning segment of the skeletal dihydropyridine receptor (DHPR), is a part of a naturally occurring muscle protein and is a high-affinity activator of skeletal and cardiac RyR channels (El-Hayek et al., 1995; Dulhunty et al., 1999; Gurrola et al., 1999; Lamb et al., 2000; Stange et al., 2001; Dulhunty et al., 2002) . Both the DHPR and the RyR are essential for skeletal muscle contraction (Tanabe et al., 1988) . A strict alignment (Block et al., 1988) allows physical coupling between the II-III loop of the DHPR and the RyR to initiate skeletal-type excitation-contraction (EC) coupling (which is independent of external Ca 2 þ ). Although the A region of the II-III loop is not required for EC coupling (Proenza et al., 2000; Wilkens et al., 2001) , it has been implicated in the overall physical interaction between the DHPR and RyR (Ahern et al., 2001) .
A sequence of positively charged residues (El-Hayek et al., 1995; Gurrola et al., 1999; Casarotto et al., 2000 Casarotto et al., , 2001 , and the alignment of the residues along one surface of the molecule (Casarotto et al., 2000; Green et al., 2003) , are critical for peptide A to activate RyR channels. Modified A peptides having the most stable a-helical structure are the strongest activators of the RyR and have a surface orientation of positively charged residues similar to that in two scorpion toxins, Imperatoxin A and Maurocalcine (Mosbah et al., 2000; Green et al., 2003) . The toxins, like the peptide, are highaffinity activators of the RyR and thought to bind to a similar site on the RyR (Tripathy et al., 1998; Gurrola et al., 1999; Green et al., 2003) . The A peptides are potentially useful as probes for RyR channel activity and would be more useful if they could be modified for membrane permeability without loss of function.
In this study, we have made the A peptides membrane permeable by conjugating them to C 12 or C 10 lipoamino acids, to alter their physico-chemical properties. Lipoamino acids are a amino acids with long alkyl side-chains, which can enhance the membrane permeability, intestinal absorption and metabolic stability of peptides and have been investigated extensively in drug delivery (Toth et al., 1999; Toth & Keri, 2003) . We have assessed the permeability of the lipoamino acid-conjugated A peptides, examined their structure and assessed their ability to release Ca 2 þ from cardiac and skeletal SR vesicles and from the SR in skinned skeletal muscle fibres. The results show that the lipid modification of the A peptides (a) increased their permeability, (b) did not significantly alter their structure, (c) enhanced their ability to activate Ca 2 þ release from isolated SR, (d) did not significantly alter their ability to activate the RyR in skinned muscle fibres and (e) enhanced a lower-affinity action of the peptide on Ca 2 þ uptake by the Ca 2 þ , Mg 2 þ ATPase in the SR.
Methods

Peptides and peptide synthesis
The A-series peptides, A1, A2, A1(D-R18) and A2(D-R18) (Table 1) were synthesised by the JCSMR Biomolecular Resource Facility using an Applied Biosystems 430A Peptide Synthesiser with purification to 98-100% using HPLC and mass spectroscopy. Stock peptide solutions (B2 mM) were prepared in H 2 O and frozen in 20 ml aliquots (Dulhunty et al., 1999) .
Lipid conjugation
Lipoamino acids, a-aminodecanoic acid and a-aminododecanoic acid were synthesised (Gibbons et al., 1990) , purified, triturated with acetonitrile, then re-crystallised. The a-aminodecanoic acid was coupled to the resin once (or twice), then coupled to peptide A2 (D-R18) to yield A2(D-R18)-C 10 (or A2(D-R18)-2C 10 ). Likewise, a-aminododecanoic acid was coupled once to A2(D-R18) to obtain A2(D-R18)-C 12 .
Sequences of A2 and A2(D-R18) and the lipoamino acid structures are:
A2(D-R18) = TSAQKAKAEERKRRKMA(D-R)GL
A2(D-R18)-C 10
A2(D-R18)-2C 10
A2(D-R18)-C 12
where -C 10 -2C 10 -C 12
Membrane permeability assessment
Caco-2 (human colon carcinoma; American Type Culture Collection) epithelial cell lines were cultivated as monolayers on permeable filters (Artursson & Karlsson, 1991) . The cells were maintained in tissue culture flasks (Nunc, Roskilde, Denmark) and seeded at B5 Â 10 5 cells cm À2 into 6.5 mm Transwells s with polycarbonate membranes (0.4 mm pore, Costar, Cambridge, U.S.A.). The culture medium (Dulbecco's modified Eagle's medium, Gibco Paisley, Scotland) was supplemented with 10% foetal calf serum, 1% nonessential amino acids, 1% L-glutamine and 1% penicillin and streptomycin. The media was replaced every 48 h, with 0.1 ml on the apical side and 0.6 ml on the basolateral side. Cells with a passage number of 55 were used in experiments. The integrity of the monolayers was monitored by the transepithelial electrical resistance (TEER) and mannitol permeability.
Apparent permeability
At 30 days after seeding, the cells were washed and equilibrated in Hanks' balanced salt solution (HBSS) at 371C on apical and basolateral sides. The cells were placed in new wells containing 0.6 ml of HBSS. In all, 200 mM of test compound was added to the apical side and the inserts transferred to new wells every 30 min over 3 h. Concentrations of test compounds in the basolateral solution were determined by liquid chromatography-mass spectrometry (LC-MS). The apparent permeability coefficient P app (cm s
À1
) was calculated as:
where DQ/Dt is the permeability rate, A is the surface area of the monolayer and C 0 is the initial concentration of the peptide on the apical side. The mannitol permeability assay was performed using D-Mannitol-1-14 C, (Sigma) as described previously (Artursson et al., 2001 ).
Electrical measurements
TEER was measured at 371C with a Millicell-electrical resistance system (ERS). The Caco-2 monolayers were incubated for 30 min, and the electrodes equilibrated for 15 min, in HBBS before TEER measurements 1 day and 30 min before, and immediately after, the experiment. The filter resistance without the cells (4-5 O cm 2 ) was subtracted from TEER values.
LC/MS analysis
A Perkin-Elmer Sciex API 3000 combined with Shimadzu HPLC was used to detect and measure peptides. A volume of 10 ml of HBBS/peptide sample was injected into the LC/MS. An Agilent C18 column (Zorbax 5 mm SB-C18 2.1 Â 50 mm 2 ) with C18 guard column and 1 : 10 splitter was used. Mobile phase A was 0.1% formic acid in H 2 O; B was 90% acetonitrile with 0.1% formic acid. The solvent gradient was started with 0% B for 0.6 min, increased to 100% B at 1.6 min, retained for 1.9 min and decreased to 0% B in 0.1 min at a constant flow of 0.2 ml min À1 . Standards were prepared from 0.001 to 5 mM. Standard curves achieved R 2 40.999.
Nuclear magnetic resonance (NMR) spectroscopy
Peptides A2(D-R18), A2(D-R18)-2C 10 and A2(D-R18)-C 12 were dissolved in 10% D 2 O/90% H 2 O to a final concentration of B2 mM at pH B5.5. NMR spectroscopy and subsequent analysis were then performed as described previously (Casarotto et al., 2000; .
Isolation of SR vesicles
Skeletal SR was isolated from the back and leg muscles of New Zealand White rabbits, and heavy SR was collected from the 35-45% (w v
À1
) interface of a discontinuous sucrose gradient, centrifuged and resuspended (Ahern et al., 1994) . Cardiac SR was prepared from sheep heart (Chamberlain & Fleischer, 1988; Laver et al., 1995) . Vesicles were frozen and stored either in liquid N 2 or at À701C.
Ca
2 þ release Extravesicular Ca 2 þ was monitored at 710 nm with the Ca 2 þ indicator, antipyrylazo III, using a Cary 3 spectrophotometer (Dulhunty et al., 1999) . Identical release experiments were performed at 790 nm, to detect Ca 2 þ -independent changes in optical density (OD), which would alter the Ca 2 þ release measurement. The cuvette solution was stirred continuously and temperature controlled at 251C. A typical Ca 2 þ -release experiment is shown in Figure 3 . Skeletal SR (100 mg of protein) was added to the cuvette solution (final volume of 2 ml), containing (mM): KH 2 PO 4 , 100 (pH ¼ 7); MgCl 2 , 4; Na 2 ATP, 1; antipyrylazo III, 0.5). Ca 2 þ , Mg 2 þ -ATPase activity was suppressed with thapsigargin (200 nM; Sagara & Inesi, 1991) . The same solutions were used with cardiac SR, except that an ATP-regenerating system -phospho(enol)pyruvate (5 mM) and pyruvate kinase (25 mg ml À1 ) -was added. OD calibration curves were obtained daily. The same conditions were used for Ca 2 þ accumulation experiments, except that the concentration of antipyrylazo III was 0.2 mM. Control experiments, performed either without SR vesicles or when the SR vesicles were blocked with thapsigargin, ruthenium red and ionophore, showed that addition of the -2C10 conjugated peptides elicited a step change in OD and then a slow increase. This artefactual change in OD was similar for all -2C10 conjugated peptides, and increased with peptide concentration from negligible levels at p1 mM peptide to values equivalent to Ca 2 þ release rates of B573 and 64710 nmol mg À1 min À1 at 5 and 30 mM peptide, respectively. Measurements of Ca 2 þ -release rate obtained in experiments where -2C10 conjugated peptide was added to Ca 2 þ -loaded vesicles were corrected for this artefact by subtracting the appropriate value. It was possible that this intrinsic optical effect was due to an isomer A2(D-R18)-2C 10 . The peptide A2(D-R18) is made with optically pure L-amino acids and D-R18. The lipoamino acid (C 10 ) was a racemate (L-C 10 and D-C 10 ), so that one C 10 conjugation gave two diastereomers and the second coupling gave four diastereomers. These diastereomers were separated by HPLC and two major fractions obtained. Fraction 1 produced much less artefactual change in OD but retained its efficacy in activating Ca 2 þ release, while fraction 4 had less functional activity and produced a strong artefactual response.
Skinned fibre techniques
Experiments were performed at 23721C and chemicals obtained from Sigma, except where noted. Mechanically skinned segments of single extensor digitorum longus (EDL) muscle fibres from the rat were connected to a force transducer (AME801, SensoNor, Horten, Norway), and bathed in a standard high [K þ ] solution mimicking the normal environment (Lamb & Stephenson, 1994) ). The SR was fully emptied of Ca 2 þ by pre-equilibrating the fibre in standard solution with 0.5 mM EGTA (pCa48) for 10 s and then exposing it to the Full Release Solution (similar solution with 30 mM caffeine, 0.05 mM free Mg 2 þ and 0.5 mM EGTA, pCa48). The time integral (area) of the force response upon emptying the SR with the Full Release Solution indicated the amount of Ca 2 þ present in the SR (Lamb et al., 2001) .
To test the sensitivity to 8 mM caffeine (e.g. Figure 9 ), the SR was loaded with Ca 2 þ to a set level (close to that in the fibre endogenously) by exposing the fibre for a set period (usually 15 s) to a solution buffered at pCa 6.7 with 1.0 mM total EGTA (Lamb et al., 2001) . The fibre was then equilibrated in standard weakly Ca 2 þ -buffered solution (1 mM Mg 2 þ , 0.05 mM EGTA, pCa 7.1) for 20 s, with or without peptide, and exposed to a similar solution with 8 mM caffeine for 15 s, before fully depleting the SR of its remaining Ca 2 þ with the Full Release Solution. Maximum Ca 2 þ -activated force in each fibre was determined using a 50 mM Ca-EGTA (pCa 4.7) ('Max') solution.
To examine the effect of a peptide on Ca 2 þ accumulation (Figure 10 ), the fibre was subjected to repeated load-deplete cycles in which the SR was loaded for a set period with peptide present or absent, and then emptied of all Ca 2 þ with the standard Full Release Solution (without peptide) to ascertain the total Ca 2 þ accumulated. When loading in standard 1 mM Mg 2 þ , the load solution was at pCa 6.7 (1 mM total EGTA), but when loading at 10 mM Mg 2 þ the free [Ca 2 þ ] was increased to pCa 6.4. Before loading, the fibre was preequilibrated for 1 min in a solution with 0.5 mM EGTA (pCa48) with or without peptide. To examine the Ca 2 þ sensitivity of the contractile apparatus, a fibre was exposed to matched sequences of solutions, both with and without the peptide, in which the [Ca 2 þ ] was heavily Ca 2 þ -buffered
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Lipid conjugation of RyR-specific peptides (50 mM total EGTA replacing HDTA) at progressively higher levels (pCa 6.7-4.7) (Lamb & Stephenson, 1994) . The steadystate force produced at each pCa was expressed relative to the respective maximum, and the force-pCa relationship was best fit with a Hill curve to give the pCa producing half-maximal force (pCa 50 ) and the Hill coefficient.
Statistics
Average data are given as mean7s.e.m. for nX4, or mean7s.d. for n ¼ 3. The significance of the difference between control and test values was tested using a Student's t-test.
Results
Membrane permeability of the peptides
The peptide sequences are shown in Table 1 . The novel A2(D-R18) contained two modifications of the native A1 sequence, which increase structural stability. Ser17 was mutated to an alanine (Casarotto et al., 2000) and the L isomer of Arg18 was replaced by the D isomer (Green et al., 2003) . The apparent permeabilities of A2(D-R18) and A2(D-R18)-2C 10 were measured and compared with a single tail of the same chain length, A2(D-R18)-C 10 . The amount of peptide transported across the Caco-2 cell monolayer increased with lipoamino acid conjugation ( Figure 1a ). The apparent permeabilities were 4.1770.5E-08 cm s À1 for A2(D-R18), 24.771.46E-08 cm s À1 for A2(D-R18)-2C 10 and 91.576.1E-08 cm s À1 for the single -C 10 conjugate. The relatively small permeability for A2(D-R18)-2C 10 was surprising, but is likely to reflect lower than expected concentrations in the donor compartment because the more hydrophobic peptide was adsorbed onto the surface of the sample well (Artursson & Karlsson, 1991) . In contrast, since A2(D-R18)-C 10 would have no significant plastic adsorption, its apparent permeability is a more accurate reflection of the true permeability of the tailed peptides. TEER values ( Figure 1b ) and the mannitol permeability assay indicated that the cells remained in good condition. TEER remained X30% of control in all cases. Toxicity is indicated by a fall to o10% of control (Ingels et al., 2002) . A smaller fall in TEER over the experimental period with both the permeable and impermeable compounds was not indicative of toxicity. Mannitol permeability, measured in parallel with compound permeability, remained between 2.4E-07 and 2.9E-07 cm s À1 and well within the normal range of 1.8E-07 to 1.17E-06 (Artursson et al., 1996) . Mannitol is restricted to the paracellular pathway across the tight junctions and its permeability indicates the tightness of the junction. The permeability will significantly increase if cells are damaged, as mannitol diffuses between the donor and the receiver compartments.
Since lipophylic compounds are excluded from paracellular pathways, it is well recognised that their permeability reflects their movement across the cell membranes, provided the cells are not damaged (Wong et al., 2002) . Since TEER and mannitol permeability indicated that the cells in this study remained in good condition, the increase in permeability 
The rate of CICR in the presence of 10 or 30 mM peptide is expressed relative to that with no added peptide (control).
Number of experiments is given in brackets. The sequence for each of the peptides is given. Residues altered from the native A1 sequence are highlighted. The Ser to Ala mutation in A2, 
Lipid conjugation of RyR-specific peptides of the -C10 conjugates is indicative of increased membrane permeability.
Structure of A2(D-R18) lipid-conjugated peptides
The complete NMR assignments were determined using standard two-dimensional methods with TOSCY experiments (Bax & Davis, 1985) to identify spin types and NOESY experiments (Kumar et al., 1980) for specific sequence assignments. The extent of a-helical structure was assessed from NOE cross-peaks, which indicate that two proton atoms are separated by Bo5 Å . Adjacent amide backbone protons in an a-helix are separated by Bo2.8 Å and typical NOE patterns reflecting a-helical structure are shown in Figure 2 . The spectrum for A2(D-R18) (Figure 2a ) indicates a helix extending throughout the entire peptide from residue 1 to 20, with a helical structure comparable to that in A1(D-R18) (Green et al., 2003) . Fewer NOESY cross-peaks were present in the spectrum for the active fraction 1 of A2(D-R18)-2C 10 ( Figure 2b ). These cross-peaks, as well as the a-proton chemical shift, indicate a helical structure between residues 2 and 15 (Casarotto et al., 2001) . Thus, the structures of the two residues closest to the lipophilic tail attachment were altered, but the key basic residues required for RyR activation (11-15) remained helical. Differences in the chemical shift patterns for A2(D-R18) and A2(D-R18)-2C 10 are due to environmental changes caused by the attachment of the lipoamino acid tail to the N-terminus.
The spectrum for the less active fraction 4 of A2(D-R18)-2C 10 (not shown) had the same number of NOE cross-peaks as fraction 1, but interestingly residues 11-15 were not fully contained within the helix. The loss of helical structure of residues 11-15 is (a) consistent with the low activity of fraction 4 (see Methods and Results) and (b) showed that isomerisation at the junction between the peptide and the lipid could cause small changes in peptide structure away from the conjugation point.
In contrast to the peptides A2(D-R18) and Fraction 1 of A2(D-R18)-2C10, A2(D-R18)-C12 displayed an NOE crosspeak pattern indicative of a partial helical structure in the critical 11-15 amino-acid region (not shown). This may explain the reduced function of this peptide (Table 1) , and is consistent with our hypothesis that this stretch of basic residues must be structurally ordered in a helical manner for optimal activation.
Lipoamino acid conjugation enhances the ability of peptides to release Ca 2 þ from SR Ca 2 þ release from skeletal SR It was shown previously that mutating Ser 17 in the A1 peptide to an alanine (A2 peptide) increased its efficacy at inducing Ca 2 þ release from thapsigargin-blocked, skeletal SR (Casarotto et al., 2000) . Furthermore, replacing the L isomer of Arg18 in A1 by the D isomer, to give A1(D-R18), also increased the efficacy (Green et al., 2003 ) (e.g. see Figure 3 ). We show here that a peptide with both changes, A2(D-R18), is even more effective than the peptides with either change alone (Figure 4) . Importantly, when A2(D-R18) was double conjugated with -C 10 , to form A2(D-R18)-2C 10 , it became considerably more effective still, with the AC 50 for resting Ca 2 þ release decreasing B5-fold to B3 mM and the maximum release rate more than doubling (Figure 4a ). Furthermore, whereas A2(D-R18) did not evoke net release of Ca 2 þ in the absence of thapsigargin (Figure 3f ), A2(D-R18)-2C 10 did so (Figure 3g) .
Fractionation of A2(D-R18)-2C 10 yielded (a) an active isomer (fraction 1), which induced Ca 2 þ release with little intrinsic absorbance change (see Methods) and (b) a less active fraction 4, which had strong intrinsic effects. Resting Ca 2 þ release was similar for the racemic mixture and the active isomer at p20 mM (Figure 4a ). The peptides also enhanced CICR and caffeine-induced Ca 2 þ release from the skeletal SR (Figure 4b ). A2(D-R18)-2C 10 was more active than A2(D-R18) and there was a further increase in activity with fraction 1.
Ca
2 þ release from cardiac SR Both conjugated and unconjugated peptides were active on cardiac SR, but their effects were small and in marked contrast to the large effect on skeletal SR. The unconjugated A2(D-R18) at 30 mM had little, if any, effect on the rate of release from the thapsigargintreated cardiac vesicles (Figure 5a ). Interestingly, double -C 10 conjugation of the peptide greatly increased its ability to induce resting Ca 2 þ release, with fraction 1 of A2(D-R18)-2C 10 apparently being more effective than the racemic mixture (Figure 5a ). In contrast, similar lipoprotein conjugation of luteinising hormone-releasing hormone (LHRH), another small peptide with an unrelated sequence 11-15 in (a, b) . These residues are the RKRRK sequence, whose helical structure is required for optimal RyR activation. The spectra for both peptides indicate that they contain a substantial helical structure that includes residues 11-15.
A2(D-R18)-2C10 (F1)
11
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Lipid conjugation of RyR-specific peptides GHWSYTGLRPG-NH2, caused no increase in resting Ca 2 þ release ( Figure 5a ). The A1 and A2 peptides had a mild potentiating effect on CICR from cardiac SR vesicles and the effect of A2(D-R18) was similar (Table 1 ). In accord with the findings on resting Ca 2 þ release, double -C10 conjugation of A2(D-R18) enhanced its potentiating effect on CICR, with fraction 1 being even more efficacious with an AC 50 of B1 mM (Figure 5b) . Interestingly, single C 12 conjugation of A2(D-R18) evidently interfered with the ability of the peptide to enhance CICR (Table 1) .
In control experiments, Ca 2 þ release induced by the peptides was shown to depend on RyR channels and thapsigargin shown to block the Ca 2 þ ATPase ( Figure 6 ). 
µM
A2(D-R18) -2C10
5 µM
A2(D-R18)
10 µM Ca Figure 7 ) reflected Ca 2 þ uptake alone and was reduced minimally by 25 mM A2(D-R18) (second column), and reduced further by 5-10 mM A2(D-R18)-2C 10 . Notably, the decrease in Ca 2 þ uptake rate with 5 mM of the -2C 10 conjugated peptide to 0.8-0.5 of control is in contrast to the 10,000-fold increase in resting Ca 2 þ release rate with the same peptide concentration (see Figure 4 above).
The protocol was altered with cardiac SR because the SR failed to accumulate 50 mM Ca 2 þ , but coped with a smaller pulse of 7.5 mM Ca 2 þ (Figure 8a and b) . The effect of ruthenium red was small (Figure 8 ), indicating that the leak through the RyR was only small, most likely due to (a) there being excess longitudinal SR (which lacks RyRs), since the cardiac preparation was not fractionated by sucrose gradient (see Methods) and (b) low loading with addition of only 7.5 mM Ca 2 þ . Thus, Ca 2 þ accumulation was dominated by Ca In (a, b) , data are shown for A2(D-R18) (RCR -n ¼ 2; CICR -n ¼ 6-9), the racemic A2(D-R18)-2C 10 (RCR -n ¼ 4; CICR -n ¼ 3) and fraction 1 (F1) of A2(D-R18)-2C 10 (RCR -n ¼ 5-7; CICR -n ¼ 3-4) and for a control peptide (LHRH) with two -C10 tails (LHRH-2C 10 ) (n ¼ 2 each for RCR and CICR). Note, in panel b that there is some CICR even in the absence of any peptide. release is through the RyR and that the Ca 2 þ pump is blocked by thapsigargin. Records show Ca 2 þ release from skeletal SR. Vesicles were loaded with 4 Â 7.5 mM Ca 2 þ (as in Figure 3a ) and 100 nM thapsigargin added as indicated. In (a), release in response to 10 mM Ca 2 þ was blocked by 5 mM ruthenium red. In (b), 5 mM ruthenium red added after 100 nM thapsigargin reduced the Ca 2 þ leak and prevented the CICR response. In (c), release with 1 mM A2(D-R18)-2C 10 was blocked by 5 mM ruthenium red. In (d, e) ruthenium red added before 1 or 5 mM peptide, respectively, prevented release. In (f), 10 mM Mg 2 þ (added after ruthenium red block) caused a step increase in optical density, but abolished residual release and the peptide-induced response. The maintained high [Ca 2 þ ] after adding ruthenium red in (a-c) indicates that the Ca 2 þ , Mg 2 þ ATPase was blocked by thapsigargin. The heavy arrow towards the end of records in (a-d, f) indicates the time of addition of Ca 2 þ ionophore A23187 (3 mg ml
À1
) to release the Ca 2 þ remaining in the TC vesicles.
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Lipid conjugation of RyR-specific peptides (Figure 8c and d) . In contrast, the racemic A2(D-R18)-2C 10 at 2.5 mM slowed the decline in [Ca 2 þ ] under all conditions to B0.8 of control. These effects were consistent with (a) a minimal influence of Ca 2 þ efflux on the measurements and (b) inhibition of the pump by A2(D-R18)-2C 10 .
Effects of lipoamino acid-conjugated peptides on skinned skeletal muscle fibres
The unconjugated A2(D-R18) potentiated caffeine-induced Ca 2 þ release in skinned EDL fibres. The peptide was more effective than A1(D-R18) (Green et al., 2003) , with 0.6 mM peptide increasing both the amplitude and rate of Ca 
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Lipid conjugation of RyR-specific peptides (Table 2 ). This effect of the peptide was substantially reversed within 2 min after washout of the peptide (not shown). A2(D-R18)-2C 10 also potentiated caffeine-induced responses (Figure 9) , with a significant increase in amplitude at 0.6 mM and a significant effect on rate at 10 mM (Table 2 ). In contrast to Ca 2 þ release from isolated SR (Figures 3 and 4) , conjugation seemingly reduced the relative effectiveness of the peptide in skinned fibres. However, this was almost certainly because the strong partitioning of the hydrophobic peptide into the membranes meant that the 20 s period allowed for full equilibration with the RyR was insufficient. (The 20 s equilibration period could not be increased because the peptide was likely to cause too great a loss of Ca 2 þ from the SR before the exposure to 8 mM caffeine.) Strong partitioning into the membrane was further indicated by the fact that the effect of A2(D-R18)-2C 10 on the caffeine response was only partially reversed after 410 min washout. Thus, the observed effects of A2(D-R18)-2C 10 on caffeine-induced Ca 2 þ release almost certainly underestimate its efficacy.
The enhancement of caffeine responses by A2(D-R18)-2C 10 was evidently due to an effect on Ca 2 þ release from the SR, not on the Ca 2 þ sensitivity of the contractile apparatus. Firstly, the force response when emptying the SR of its remaining Ca 2 þ after exposure to 8 mM caffeine was smaller when peptide had been present in the 8 mM caffeine solution (Figure 9 ). Such a reduced response indicates that the presence of the peptide in the 8 mM caffeine solution caused greater depletion of Ca 2 þ in the SR. Secondly, direct examination of the contractile apparatus showed that A2(D-R18)-2C 10 (at 3 mM) had no effect on maximum force or Ca 2 þ sensitivity (pCa 50 and Hill coefficient: 5.9670.01 and 4.470.6, and 5.9670.01 and 4.270.7, with and without peptide, respectively; P40.05, Student's paired t-test, n ¼ 4).
A2(D-R18)-2C 10 substantially inhibited net Ca 2 þ accumulation by the SR (Figure 10a ). In these experiments, where the SR was initially empty of Ca 2 þ , it was possible to equilibrate the fibres with peptide for 1 min before testing its effect on Ca 2 þ accumulation. The effect of the conjugated peptide on Ca 2 þ accumulation became greater with repetition (stabilising after B3 repetitions), consistent with a slow time-course for full equilibration of the peptide within the fibre. A2(D-R18)-2C 10 (10 mM) reduced the net uptake rate to 1874% of control In each skinned fibre, the force response to 8 mM caffeine was measured twice in the absence of peptide (and averaged) and then twice in the presence of the peptide (tests 1 and 2) (see Figure 9) , and expressed as a percentage of the maximum Ca
2+
-activated force in that fibre. The table shows the mean7s.e.m. data obtained in the indicated number of fibres (n). Note that, although the size of control response to 8 mM caffeine could differ somewhat between fibres, it was highly reproducible within a given fibre (e.g. Figure 9 ), and that paired control and test data were always obtained in each fibre. *Significant difference (Po0.05) between control and test response (Student's one-tailed paired t-test).
Figure 9 A2(D-R18)-2C10 potentiates caffeine-induced Ca 2 þ release in a skinned EDL fibre. A skinned EDL fibre was subjected to repeated cycles in which the SR was emptied of all Ca 2 þ and then reloaded to a set level and the responsiveness to 8 mM caffeine tested. The response to 8 mM caffeine was greatly potentiated by 10 mM A2(D-R18)-2C10. After testing the response to 8 mM caffeine, the SR was depleted of its remaining Ca 2 þ by exposure to the Full Release Solution, with the area of the resulting force response being indicative of the amount of Ca 2 þ that was in the SR. When 8 mM caffeine elicited a bigger force response, and hence more Ca 2 þ release, the amount of Ca 2 þ left in the SR decreased. Note that the 'area' of the force response to 8 mM caffeine cannot be directly compared to that when fully releasing the Ca 2 þ because of the very different levels of Ca 2 þ buffering in the two cases. The peptide was added 20 s before testing the responsiveness to 8 mM caffeine. 'Max' indicates maximum Ca 2 þ -activated force for the fibre.
(on the third repetition in peptide) (n ¼ 6 fibres). The effect was slowly reversed by washout (taking B10 min for near full recovery, legend to Figure 10 ). The effect of the peptide in reducing net Ca 2 þ accumulation was consistent with it enhancing Ca 2 þ efflux through the RyR during the Ca 2 þ -loading period. The greater effect with successive repetitions and slow washout are consistent with retarded equilibration of the peptide at its active site.
The possibility that the conjugated peptide also slowed Ca 2 þ uptake by the Ca 2 þ pump was examined by blocking Ca 2 þ efflux with 10 mM free Mg 2 þ -a potent inhibitor of the RyR (Lamb & Stephenson, 1994) . Under such circumstances, 10 mM of A2(D-R18)-2C 10 reduced net uptake to only 7178% of control (n ¼ 6 fibres, Po0.05) (e.g. Figure 10b ). The fact that uptake still declined when the RyR was disabled indicates that the peptide directly inhibits the SR Ca 2 þ pump. Nevertheless, it is apparent that most of the reduction in net Ca 2 þ accumulation observed at normal [Mg 2 þ ] (e.g. Figure 10a ) was due to the peptide potentiating the Ca 2 þ efflux from the SR during Ca 2 þ loading. These results are in close accord with those found in the skeletal SR vesicles.
Discussion
We find that peptides, with sequences based on the A region of the skeletal muscle DHPR II-III loop, become permeable in a Caco-2 cell line assay following lipoamino acid conjugation. Importantly, the conjugation did not significantly alter the ahelical structure of residues that are critical for high-affinity activation of RyR Ca 2 þ channels, and did not interfere with the ability of the peptides to release Ca 2 þ from the SR. In fact, the conjugation increased the efficacy of the peptides in inducing Ca 2 þ release from both skeletal and cardiac SR.
Permeability of lipoamino acid-conjugated peptides
As shown previously with other peptides (Wong et al., 2002) , the lipoamino acid conjugation enhanced the ability of the poorly absorbed native peptides to cross the epithelial cell layer. In order for a compound to be well absorbed, it should have an apparent permeability in Caco-2 monolayers of B1 Â 10 À6 cm s À1 (Artursson & Karlsson, 1991) . Since A2(D-R18)-C10 had a P app value of 0.97 Â 10
À6
, it should be well absorbed in vivo. Passive transport pathways across the epithelium are through tight junctions and across the apical and basolateral cell membranes (Artursson et al., 2001; Wong et al., 2002) . The poorly permeable hydrophilic A2(D-R18) probably diffused through tight junctions, which provide the usual route for water-soluble compounds. The enhanced permeability of the hydrophobic lipoamino acid conjugates suggested that they crossed the cell membranes. The low apparent permeability of the more hydrophobic A2(D-R18)-2C 10 (compared with A2(D-R18)-C 10 ), can be explained by a lower than expected [peptide] in the donor solution, due to lower solubility and tendency to adsorb onto the chamber wall. High adsorbance can reduce apparent permeability by at least an order of magnitude (Artursson & Karlsson, 1991) .
Structure of the conjugated peptides
The ability of the A peptides to stimulate Ca 2 þ release through the RyR depends on the presence of a stretch of positively charged amino-acid residues along one surface of the a-helical Figure 10 Peptide A2(D-R18)-2C10 reduces net Ca 2 þ uptake by the SR in a skinned EDL fibre when present in the loading solution. In (a), force responses were elicited when emptying the SR with the Full Release Solution after loading for the indicated time, under the standard conditions with 1 mM Mg 2 þ (pCa 6.7, 1 mM total EGTA), with or without peptide. The area of the force response is indicative of the net amount of Ca 2 þ loaded into the SR. The peptide reduced net Ca 2 þ uptake and the effect became greater on successive repetitions (stabilising after B3 repetitions) and was reversed only slowly by washout. The records shown are for the third repetition after loading in the presence of the peptide, and the following control records are for the fourth load/release cycle after washout of the peptide. In the fibre shown in (b), A2(D-R18)-2C10 caused only a small reduction in net SR Ca 2 þ uptake when there was 10 mM free Mg 2 þ in the loading solution. The reduced effect of the peptide was due to the high [Mg 2 þ ] inhibiting activation of the Ca 2 þ release channels and preventing the peptide from increasing Ca 2 þ efflux from the SR during uptake. These findings indicate that most of the reduction in net Ca 2 þ uptake by the peptide in (a) is due to increased Ca 2 þ efflux, not reduced uptake. (Note that the rate of Ca 2 þ uptake is reduced in 10 mM Mg 2 þ but this effect was minimised by raising the [Ca 2 þ ] in the load solution from pCa 6.7 to 6.4, so that the net Ca 2 þ loaded into the SR is comparable with that in (a)). In (a, b) Ca 2 þ release was evoked under the standard conditions with 1 mM Mg 2 þ .
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A.F. Dulhunty et al Lipid conjugation of RyR-specific peptides peptide (Casarotto et al., 2000; Green et al., 2003) . The profile of the NOESY spectra provides sufficient information to assess the integrity of secondary structure without performing a full structural analysis. The NOE cross-peak pattern in the amide region showed that the helical nature of the peptides was essentially retained despite the modification of the N-terminus by the lipoamino acid attachment. In particular, it was shown that the involvement of a helix for residues 11-15 was still a requirement in order for these peptides to release Ca 2 þ from the SR. This point was clearly evident for the two fractions of A2(D-R18)-2C 10 where the stereochemistry related to the lipophilic attachment influenced the structure of the peptide portion and hence the functional response of the peptide. Thus, functional changes in the conjugated peptides can be attributed to the increased hydrophobicity of the peptide, rather than altered peptide structure.
RyR activation by lipoamino acid-conjugated peptides
The lipoamino acid conjugation of A2(D-R18) considerably enhanced its ability to release Ca 2 þ from isolated SR. Since the control LHRH-2C 10 peptide did not release Ca 2 þ or enhance CICR, the lipoamino acid tails per se did not contribute to Ca 2 þ release.
Different actions of the peptides on skeletal and cardiac SR
The effects of the A peptides on skeletal SR were significantly stronger than the effects on cardiac SR. The lower sensitivity of the cardiac preparation presumably reflects differences between the binding sites or in the environment of the binding site in different RyR isoforms. A further reflection of possible differences in the environment of the binding site is the fact that the active fraction 1 (F1) of A2(D-R18)-2C 10 was as effective as the racemic A2(D-R18)-2C 10 in releasing Ca 2 þ in the skeletal preparation, but was substantially more effective in the cardiac preparation (although its effect remained far less than that on skeletal SR).
Slow equilibration of lipoamino acid-conjugated peptides in skinned fibres
In contrast to the greater efficacy of the lipoamino acidconjugated peptides in releasing Ca 2 þ from isolated SR, A2(D-R18)-C 10 was less effective in enhancing caffeineinduced Ca 2 þ release in skinned fibres when equilibration times were brief (B20 s). However, when the preparation was successively exposed to A2(D-R18)-C 10 (with 1 min equilibration during each exposure), a progressively greater effect on Ca 2 þ accumulation was observed, which was attributed to enhanced Ca 2 þ efflux. This indicated that equilibration of the conjugated peptide at its active site was slower than accumulation of the unconjugated peptide. Slow equilibration is consistent with the hydrophobic peptide partitioning into the lipid of the t-tubule and SR membranes that surround the RyR and form two boundaries of the restricted space of the triad junction (Franzini-Armstrong, 1970) , as seen in the skinned fibres with other lipid-permeable agents such as nifedipine (Posterino & Lamb, 1998) . It is also evidence that the conjugated peptides readily permeate the cell membranes of muscle fibres.
Lipoamino acid conjugation of the A peptides reveals an action on the Ca 2 þ pump A small and low-affinity effect of the conjugated A peptides on the Ca 2 þ , Mg 2 þ ATPase was apparent. Since fast-twitch skeletal and cardiac SR contain different isoforms of SR, endoplasmic reticulum Ca 2 þ ATPase (SERCA), SERCA1 and SERCA2a, respectively (MacLennan et al., 1997), the effect is not isoform specific. A small decline in Ca 2 þ uptake by skeletal SR exposed to the unconjugated A2(D-R18) suggested that the hydrophilic peptide may have restricted access to an inhibitory site located in a hydrophobic region of the protein.
Potential use for lipoamino acid-conjugated A peptides
Within a limited concentration range, A2(D-R18)-2C 10 is a specific activator of the skeletal RyR in SR vesicles and skinned fibres. A2(D-R18)-2C 10 at 2 mM produced an B2000-fold increase in Ca 2 þ release from skeletal SR without affecting the Ca 2 þ pump. At higher concentrations where small effects on the cardiac RyR and on Ca 2 þ uptake by the Ca 2 þ , Mg 2 þ ATPase were apparent, the activation of RyR1 was several orders of magnitude greater than the effects on RyR2 or the SERCA proteins. The peptide at 20 mM caused a 20,000-fold increase in Ca 2 þ release from skeletal SR, compared with only a four-fold reduction in Ca 2 þ uptake. The peptide enhanced caffeine-induced Ca 2 þ release in skinned fibres at 0.6 mM, and at 10 mM increased caffeineinduced Ca 2 þ release B6-fold with only a 30% decline in pump activity. Therefore, A2(D-R18)-2C 10 is a membranepermeable peptide that selectively activates Ca 2 þ release from skeletal SR through RyR channels at concentrations p2 mM.
In conclusion, the experiments show that lipoamino acid conjugation renders the A peptides membrane permeable, without significantly altering either the a-helical secondary structure of a critical region of the peptides or altering their ability to stimulate RyR activity. The present study constitutes proof of principal that lipoamino acid conjugation of A peptides is a potentially promising method for developing membranepermeable specific stimulators of RyRs for use in vivo.
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